Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort StudyAlexis Tabah, Jean‐François Timsit, Despoina Koulenti et al.|Intensive Care Medicine|2012Cited by 449
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteriaMatteo Bassetti, Garyphallia Poulakou, Jan J. De Waele et al.|Intensive Care Medicine|2015Cited by 182
A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal InfectionsWolfgang Knitsch, Oliver A. Cornely, Jean‐Louis Vincent et al.|Clinical Infectious Diseases|2015Cited by 99
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Tomas Hruby, Apostolos Komnos et al.|Critical Care|2022Cited by 93
Therapeutic management of peritonitis: a comprehensive guide for intensivistsPhilippe Montravers, Jan J. De Waele, Stijn Blot et al.|Intensive Care Medicine|2016Cited by 93